Cristcot Inc. Expands Distribution of Sephure Suppository Applicators to Australia
Global life sciences company, Cristcot Inc., secures distribution partnership
with Gallay Medical & Scientific Pty Ltd for Sephure suppository applicator
Global life sciences company, Cristcot Inc., secures distribution partnership
with Gallay Medical & Scientific Pty Ltd for Sephure suppository applicator
CONCORD, MA, February 26, 2015 — Cristcot Inc., a global life sciences company, today announced a new distribution partnership with Gallay Medical & Scientific Pty Ltd to distribute Sephure suppository applicators in Australia.
The partnership is an extension of Cristcot’s distribution of Sephure applicators to international markets. Recognized by healthcare providers globally as an improvement in quality care, Sephure applicators will be available to patients and caregivers in Australia for the comfortable and hygienic administration of suppository medication.
“On behalf of Gallay Medical & Scientific Pty Ltd, we look forward to bringing Sephure applicators to the Australian market,” said Chris Pezet, Director of Sales at Gallay. “We are thrilled about this partnership and what this applicator can do for people who need or are looking for an improved way to administer suppository medication.”
Gallay is a recognized leader in gastroenterological supplies throughout Australia, and anticipates launching Sephure to the Australian market in the next few weeks.
“We are delighted to extend our distribution partnership with Gallay in Australia,” said Jennifer Davagian Ensign, Founder & CEO of Cristcot Inc. “By expanding distribution of Sephure applicators to Australia, we are helping improve quality healthcare for patients and healthcare providers.”
The partnership is an extension of Cristcot’s distribution of Sephure applicators to international markets. Recognized by healthcare providers globally as an improvement in quality care, Sephure applicators will be available to patients and caregivers in Australia for the comfortable and hygienic administration of suppository medication.
“On behalf of Gallay Medical & Scientific Pty Ltd, we look forward to bringing Sephure applicators to the Australian market,” said Chris Pezet, Director of Sales at Gallay. “We are thrilled about this partnership and what this applicator can do for people who need or are looking for an improved way to administer suppository medication.”
Gallay is a recognized leader in gastroenterological supplies throughout Australia, and anticipates launching Sephure to the Australian market in the next few weeks.
“We are delighted to extend our distribution partnership with Gallay in Australia,” said Jennifer Davagian Ensign, Founder & CEO of Cristcot Inc. “By expanding distribution of Sephure applicators to Australia, we are helping improve quality healthcare for patients and healthcare providers.”
沒有留言:
發佈留言